Heligenics

[On Demand]
Search General Info
Search Education
Search Partnering Companies
Heligenics was formed to implement the GigaAssay to produce saturating mutation/function maps for key genes already established for inherited disease, cancer diagnostics, or gene targets associated with actionable therapies. The GigaAssay is a massively parallelized platform for assaying molecular functions of single cells in culture without the need for mechanical separation of the cells. As a massively parallel biological assay that can simultaneously measure how millions of genetic variants or other sequence variables affect the molecular function or cell process, this would take many years if not decades to accomplish using conventional methods. To date, there are no other established assays that assess cell processes and molecular functions in human cells at this scale. There are many applications to drug development and genetic diagnostics.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Nevada
Company HQ Country:
United States
Year Founded:
2017
Main Therapeutic Focus:
Lead Product in Development:
Gene Mutation/Function Libraries
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
3
Speaker
photo
CEO
Heligenics